Cite

HARVARD Citation

    Sonnenblick, A. et al. (n.d.). 218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial. Annals of oncology. p. . [Online]. 
  
Back to record